尼妥珠单抗
医学
内科学
放化疗
不利影响
放射治疗
临床终点
肿瘤科
粘膜炎
前瞻性队列研究
胃肠病学
临床试验
癌症
表皮生长因子受体
作者
Nuo Yu,Guowei Cheng,Jiao Li,Jun Liang,Tao Zhang,Lei Deng,Wenyang Liu,Jianyang Wang,Yirui Zhai,Wenqing Wang,Zefen Xiao,Zongmei Zhou,Dongfu Chen,Qinfu Feng,Nan Bi,Xin Wang
出处
期刊:Current Cancer Drug Targets
[Bentham Science]
日期:2023-03-16
卷期号:23 (8): 653-662
被引量:3
标识
DOI:10.2174/1568009623666230315145937
摘要
Concurrent or definitive chemoradiotherapy is the standard treatment of locally advanced esophageal squamous cell carcinoma (ESCC). Elderly patients could not tolerate the standard concurrent chemotherapy and were treated with radiotherapy because of weak physical status and multiple comorbidities.
科研通智能强力驱动
Strongly Powered by AbleSci AI